Aug 04, 2024
Andrew Terker, MD, PhD, Assistant Professor of Medicine (Nephrology and Hypertension), and a a multidisciplinary research team have identified a protein in the kidney that responds to low levels of blood potassium and the signaling pathways that it uses to change kidney function.
Their findings, published in Nature Communications, suggest that the protein — a potassium channel called Kir4.2 — may be a target for new therapeutics to treat kidney disease, high blood pressure and other cardiovascular diseases.